2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) reverses hyperglycemia in a type II diabetes mellitus rat model by a mechanism unrelated to PPARγ

References

• American Diabetes Association. (2006) Available at: www.diabetes.org/diabetes-statistics.jsp (Accessed 2006).
   Google Scholar
• Aylward, L. L., Hays, S. M. (2002). Temporal trends in human TCDD body burden, decreases over three decades, and implications for exposure levels. J Expo Anal Environ Epidemiol 12:319–328.
   PubMedGoogle Scholar
• Brewster, D. W., Bombick, D. W., Matsumura, F. (1988). Rabbit serum hypertriglyceridemia after administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD. J Toxicol Environ Health 25:495–507.
   PubMed Web of Science ®Google Scholar
• Calvert, G. M., Sweeney, M. H., Deddens, J., Wall, D. K. (1999). Evaluation of diabetes mellitus, serum glucose, and thyroid function among United States workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Occup Environ Med 56:270–276.
   PubMed Web of Science ®Google Scholar
• Chapman, D. E., Schiller, C. M. (1985). Dose-related effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD in C57BL/6J and DBA/2J mice. Toxicol Appl Pharmacol 78:147–157.
   PubMed Web of Science ®Google Scholar
• Chen, C. L., Brodie, A. E., Hu, C. Y. (1997). CCAAT/enhancer-binding protein beta is not affected by tetrachlorodibenzo-p-dioxin, TCDD. Inhibition of 3T3-L1 preadipocyte differentiation. Obes Res 5:146–152.
   PubMedGoogle Scholar
• Ebner, K., Brewster, D. W., and Matsumura, F. (1988). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on serum insulin and glucose levels in the rabbit. J Environ Sci Health B 23:427–438.
   PubMed Web of Science ®Google Scholar
• Gorski, J. R., Rozman, K. (1987). Dose-response and time course of hypothyroxinemia and hypoinsulinemia and characterization of insulin hypersensitivity in 2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD-treated rats. Toxicology 44:297–307.
   PubMed Web of Science ®Google Scholar
• Gorski, J. R., Weber, L. W., Rozman, K. (1990). Reduced gluconeogenesis in 2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD-treated rats. Arch Toxicol 64:66–71.
   PubMed Web of Science ®Google Scholar
• Grossman, S. L., and Lessem, J. (1997). Mechanisms and clinical effects of thiazolodinediones. Exp Opin Invest Drugs 6:1025–1040.
   PubMedGoogle Scholar
• Gui, Y., Silha, J. V., Mishra, S., Murphy, L. J. (2003). Changes in adipokine expression during food deprivation in the mouse and the relationship to fasting-induced insulin resistance. Can J Physiol Pharmacol 81:979–985.
   PubMed Web of Science ®Google Scholar
• Guo, G. L., Lambert, G., Negishi, M., Ward, J., Jr., Brewer, H. B., Kliewer, S. A., et al. (2003). Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J Biol Chem 278:45062–45071.
   PubMed Web of Science ®Google Scholar
• Hardman, J. G., Limbird, L. E., Gilman, A. G. (Eds.), (2001). Goodman & Gilman’s The Pharmacological Basis of Therapeutics. New York: The McGraw-Hill.
   Google Scholar
• Henriksen, G. L., Ketchum, N. S., Michalek, J. E., Swaby, J. A. (1997). Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand. Epidemiology 8:252–258.
   PubMed Web of Science ®Google Scholar
• Li, Y., Bujo, H., Takahashi, K., Shibasaki, M., Zhu, Y., Yoshida, Y., et al. (2003). Visceral fat, higher responsiveness of fat mass, and gene expression to caloric restriction than subcutaneous fat. Exp Biol Med 10:1118–1123.
   Google Scholar
• Liu, X., Jefcoate, C. (2006). 2,3,7,8-tetrachlorodibenzo-p-dioxin and epidermal growth factor cooperatively suppress peroxisome proliferator-activated receptor-gamma1 stimulation and restore focal adhesion complexes during adipogenesis, selective contributions of Src, Rho, and Erk distinguish these overlapping processes in C3H10T1/2 cells. Mol Pharmacol 70:1902–1915.
   PubMed Web of Science ®Google Scholar
• Muzi, G., Gorski, J. R., Rozman, K. (1989). Mode of metabolism is altered in 2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD-treated rats. Toxicol Lett 47:77–86.
   PubMed Web of Science ®Google Scholar
• Nishiumi, S., Yabushita, Y., Furuyashiki, T., Fukuda, I., Ashida, H. (2008). Involvement of SREBPs in 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced disruption of lipid metabolism in male guinea pig. Toxicol Appl Pharmacol 229:281–289.
   PubMed Web of Science ®Google Scholar
• Reed, M. J., Meszaros, K., Entes, L. J., Claypool, M. D., Pinkett, J. G., Gadbois, T. M., et al. (2000). A new rat model of type 2 diabetes, the fat-fed, streptozotocin-treated rat. Metabolism 49:1390–1394.
   PubMed Web of Science ®Google Scholar
• Remillard, R. B. J., Bunce, N. J. (2002). Linking dioxins to diabetes, epidemiology, and biologic plausibility. Environ Health Perspect 110:853–858.
   PubMed Web of Science ®Google Scholar
• Sawant, S. P., Dnyanmote, A. V., Shankar, K., Limaye, P. B., Latendresse, J. R., Mehendale, H. M. (2004). Potentiation of carbon tetrachloride hepatotoxicity and lethality in type 2 diabetic rats. J Pharmacol Exp Ther 308:694–704.
   PubMed Web of Science ®Google Scholar
• Seefeld, M. D., Keesey, R. E., Peterson, R. E. (1984). Body weight regulation in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 76:526–536.
   PubMed Web of Science ®Google Scholar
• Seefeld, M. D., Peterson, R. E. (1984). Digestible energy and efficiency of feed utilization in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 74:214–222.
   PubMed Web of Science ®Google Scholar
• Sweeney, M. H., Calvert, G. M., Egeland, G. A., Fingerhut, M. A., Halperin, W. E., Piacitelli, L. A. (1997). Review and update of the results of the NIOSH medical study of workers exposed to chemicals contaminated with 2,3,7,8-tetrachlorodibenzodioxin. Teratog Carcinog Mutagen 17:241–247.
   PubMedGoogle Scholar
• Vidal-Puig, A., Jimenez-Linan, M., Lowell, B. B., Hamann, A., Hu, E., Spielman, B., et al (1996). Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest 97:2553–2561.
   PubMed Web of Science ®Google Scholar
• Vogel, C. F., Matsumura, F. (2003). Interaction of 2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD with induced adipocyte differentiation in mouse embryonic fibroblasts, MEFs, involves tyrosine kinase c-Src. Biochem Pharmacol 66:1231–1244.
   PubMed Web of Science ®Google Scholar
• Weber, L. W., Lebofsky, M., Greim, H., Rozman, K. (1991a). Key enzymes of gluconeogenesis are dose-dependently reduced in 2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD-treated rats. Arch Toxicol 65:119–123.
   PubMed Web of Science ®Google Scholar
• Weber, L. W., Lebofsky, M., Stahl, B. U., Gorski, J. R., Muzi, G., Rozman, K. (1991b). Reduced activities of key enzymes of gluconeogenesis as possible cause of acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD in rats. Toxicology 66:133–144.
   PubMed Web of Science ®Google Scholar
• Weber, L. W. D., Stahl, B. U., Lebofsky, M., Alper, R. H., Kerecsen, L., Rozman, K. K. (1991c). Inhibition of phosphoenolpyruvate carboxykinase activity appears to be the key biochemical lesion in the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Chemosphere 23:1957–1962.
   Web of Science ®Google Scholar